ArticleTheranostics2023

Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting.

Marco Erreni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.